Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Penny Lovat.

Newcastle AuthorsTitleYearFull text
Jan Lecouturier
Dr Helen Bosomworth
Dr Marie Labus
Dr Robert Ellis
Professor Penny Lovat
et al.
Health professional and patient views of a novel prognostic test for melanoma: A theoretically informed qualitative study2022
Dr Francesco Zummo
Merilin Georgiou
Kirsty Cullen
Minna Honkanen-Scott
Professor James Shaw
et al.
Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis2021
Dr Ioana Cosgarea
Dr Ashleigh McConnell
Dr Tom Ewen
Dr Diana Tang
Dr David Hill
et al.
Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration2021
Professor Luke Vale
Patience Kunonga
Dr Diarmuid Coughlan
Vasileios Kontogiannis
Margaret Astin
et al.
Optimal surveillance strategies for Patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model2021
Krishan Mistry
Tom Clifford
Dr Marie Labus
Professor Penny Lovat
Dr Ashleigh McConnell
et al.
Potentiating Cutaneous Wound Healing in Young and Aged Skin with Nutraceutical Collagen Peptides2021
Tom Andrew
Professor Penny Lovat
Predictive indicators for revisional surgery in nasal reconstruction after Mohs surgery2021
Dr Robert Ellis
Dr Diana Tang
Dr Batoul Nasr
Alison Greenwood
Dr Ashleigh McConnell
et al.
Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas2020
Dr Robert Ellis
Benjamin Cosway
Dr Marie Labus
Professor Penny Lovat
HPV sensitizes OPSCC cells to cisplatin-induced apoptosis by inhibiting autophagy through E7-mediated degradation of AMBRA12020
Dr Chiao-En Wu
Tsin Koay
Professor Penny Lovat
Professor John Lunec
TP53 mutant cell lines selected for resistance to MDM2 inhibitors retain growth inhibition by MAPK pathway inhibitors but a reduced apoptotic response2019
Dr Chiao-En Wu
Tsin Koay
Arman Esfandiari
Professor Penny Lovat
Professor John Lunec
et al.
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous Melanoma2019
Dr Stamatina Verykiou
Michael Alexander
Dr Noel Edwards
Professor Ruth Plummer
Dr Bill Chaudhry
et al.
Harnessing autophagy to overcome MEK-inhibitor induced resistance in metastatic melanoma2019
Dr John Widdrington
Dr Aurora Gomez Duran
Dr Angela Pyle
Dr Marie-Helene Ruchaud
Jonathan Scott
et al.
Exposure of Monocytic Cells to Lipopolysaccharide Induces Coordinated Endotoxin Tolerance, Mitochondrial Biogenesis, Mitophagy, and Antioxidant Defenses2018
Arman Esfandiari
Nan Wang
Dr Ahmed Mahdi
Erhan Aptullahoglu
Professor Penny Lovat
et al.
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeuticstrategy in cutaneous melanoma2018
Dr Francesco Zummo
Kirsty Cullen
Minna Honkanen-Scott
Professor James Shaw
Professor Penny Lovat
et al.
Glucagon-like peptide-1 protects pancreatic beta-cells from death by increasing autophagic flux and restoring lysosomal function2017
Dr Bernadette Carroll
Dr Glyn Nelson
Dr Yoana Rabanal Ruiz
Dr Olena Kucheryavenko
Professor Penny Lovat
et al.
Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing2017
Dr Jane Renwick
Christopher McKee
Professor Penny Lovat
Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization.2016
Dr Francesco Zummo
Kirsty Cullen
Professor Penny Lovat
Professor James Shaw
Dr Catherine Arden
et al.
Glucagon-like peptide-1 requires EPAC activity to restore autophagy and protect pancreatic beta cells from cell death2016
Dr Viktor Korolchuk
Dr Bernadette Carroll
Professor Penny Lovat
Dr Nuria Martinez Lopez
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd Ed.)2016
Moyassar Al-Shaibani
Dr Xiao Wang
Professor Penny Lovat
Professor Anne Dickinson
Mesenchymal stem cells promote wound healing via differentiation into epidermal keratinocyte-like cells2016
Dr Diana Tang
Dr Robert Ellis
Professor Penny Lovat
Prognostic impact of autophagy biomarkers for cutaneous melanoma2016
Dr Bernadette Carroll
Dr Long Xie
Professor Penny Lovat
Dr Viktor Korolchuk
Targeting the persistent activation of mammalian target of rapamycin in BRAF mutated melanoma as a novel therapeutic strategy2016
Dr Viktor Korolchuk
Dr Bernadette Carroll
Dr Long Xie
Carola Dostal
Professor Penny Lovat
et al.
Targeting the persistent activation of mTOR in B-RAF and NRas mutated melanoma as a novel therapeutic strategy2016
Emma Woodward
Madona Elias
Professor Penny Lovat
Professor Nick Reynolds
TCDD-mediated induction of a chloracne phenotype is associated with aryl hydrocarbon receptor activation, deregulated epidermal differentiation, apoptosis and lysosomal processing2016
Ashleigh McConnell
Dr Robert Ellis
Professor Ruth Plummer
Professor Penny Lovat
Dr Graeme O'Boyle
et al.
The prognostic significance and impact of the CXCR4-CXCR7-CXCL12 axis in primary cutaneous melanoma2016
Dr David Hill
Dr Jane Renwick
Professor Penny Lovat
A novel fully-humanised 3D skin equivalent to model early melanoma invasion2015
Dr Francesco Zummo
Kirsty Cullen
Professor Penny Lovat
Professor James Shaw
Dr Catherine Arden
et al.
An emerging role for autophagy in the regulation of beta cell survival by glucagon-like peptide-12015
Dr Stamatina Verykiou
Professor Ruth Plummer
Professor Penny Lovat
Contribution of autophagy to the survival of melanoma-initiating CD271-positive subpopulations2015
Moyassar Al-Shaibani
Dr Xiao Wang
Professor Penny Lovat
Professor Anne Dickinson
Deciphering the Role of Mesenchymal Stem Cells Paracrine in Wound Closure Acceleration2015
Dr Jane Renwick
Dr David Hill
Christopher McKee
Maria Anagnostou
Fiyinfoluwa Babatunde
et al.
Exploiting Cannabinoid-Induced Cytotoxic Autophagy to Drive Melanoma Cell Death2015
David Hill
Professor Penny Lovat
G1 phase melanoma cells escape proteasome inhibitor cytotoxicity2015
Dr Francesco Zummo
Kirsty Cullen
Professor Penny Lovat
Professor James Shaw
Dr Catherine Arden
et al.
Glucagon-like peptide 1 protects pancreatic beta cells from programmed cell death: a role for autophagy2015
Dr David Hill
Professor Penny Lovat
Making stressed melanoma self-destruct2015
Dr David Hill
Professor Penny Lovat
Melanoma cells in G1 phase escape proteasome inhibitor cytotoxicity2015
Professor Penny Lovat
Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma2015
Ashleigh McConnell
Dr Graeme O'Boyle
Professor Matthew Wright
Professor Penny Lovat
Targeting mitogen-activated protein kinase kinase to prevent CXCR4-CXCL12 chemotaxis in cutaneous melanoma2015
Dr Bernadette Carroll
Professor Penny Lovat
Dr Viktor Korolchuk
Targeting the persistent activation of mammalian target of rapamycin in BRAF- and NRas-mutated melanoma as a novel therapeutic strategy2015
Dr Robert Ellis
Dr Stamatina Verykiou
Maria Anagnostou
Derek Hill
Professor Penny Lovat
et al.
Transforming growth factor-beta mediates loss of epidermal integrity and melanoma ulceration2015
Shaun Martin
Professor Penny Lovat
Dr Chris Redfern
Cell-Type Variation in Stress Responses as a Consequence of Manipulating GRP78 Expression in Neuroectodermal Cells2014
Dr Stamatina Verykiou
Dr Robert Ellis
Professor Penny Lovat
Established and Emerging Biomarkers in Cutaneous Malignant Melanoma2014
Dr Nigel Kirkham
Professor Penny Lovat
Dr Neil Rajan
Increased p62 expression in CYLD-defective tumours: indication of an autophagic dependency?2014
Dr David Hill
Professor Penny Lovat
Induction of endoplasmic reticulum stress as a strategy for melanoma therapy2014
Dr David Hill
Dr Stamatina Verykiou
Dr Bill Chaudhry
Professor Penny Lovat
Modelling melanoma metastasis using organotypic skin equivalent and zebrafish models2014
Maria Anagnostou
Professor Penny Lovat
Dr Robert Ellis
Proautophagic Ambra-1 as biomarker of differentiation in cutaneous squamous carcinoma2014
Dr Robert Ellis
Jonathan Lumsdon
Dr Nigel Kirkham
Dr Jane Renwick
Professor Penny Lovat
et al.
Prognostic Impact of p62 Expression in Cutaneous Malignant Melanoma2014
Ashleigh McConnell
Dr Robert Ellis
Dr Graeme O'Boyle
Professor Ruth Plummer
Dr Stamatina Verykiou
et al.
Prognostic significance of CXCR4 expression in cutaneous melanoma2014
Dr Robert Ellis
Maria Anagnostou
Dr Stamatina Verykiou
Martina Elias
Dr Nigel Kirkham
et al.
Transforming growth factor-beta-mediated Ambra-1 downregulation in melanoma ulceration and metastasis2014
Professor Mark Birch-Machin
Dr Robert Ellis
Dr Jane Renwick
Professor Penny Lovat
Increasing the therapeutic efficacy of docetaxel for cutaneous squamous cell carcinoma through the combined inhibition of phosphatidylinositol 3-kinase/AKT signalling and autophagy2013
Shaun Martin
Dr Heather Lamb
Paul Thompson
Professor Penny Lovat
Professor Alastair Hawkins
et al.
Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP782013
Dr Graeme O'Boyle
Isabella Swidenbank
Dr Helen Marshall
Catriona Barker
Dr Jane Renwick
et al.
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD110702013
Christopher McKee
Dr David Hill
Dr Chris Redfern
Dr Jane Armstrong
Professor Penny Lovat
et al.
Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma2013
Dr Robert Ellis
Dr Stamatina Verykiou
Jonathan Lumsdon
Dr Jane Renwick
Dr Nigel Kirkham
et al.
Peri-tumoural expression of pro-autophagic Ambra-1 as a prognostic biomarker for melanoma2013
Dr David Hill
Professor Penny Lovat
Optimization of endoplasmic reticulum (ER) stress-inducing therapies for melanoma using real-time cell cycle imaging2012
Dr Robert Ellis
Dr Jane Renwick
Dr Nigel Kirkham
Professor Penny Lovat
p62 as a biomarker of malignant melanoma2012
Dr Robert Ellis
Dr Jane Renwick
Dr Nigel Kirkham
Professor Penny Lovat
p62: a novel diagnostic and prognostic biomarker of malignant melanoma2012
Dr Jane Renwick
Shaun Martin
Nicola Illingworth
Dr David Jamieson
Professor Penny Lovat
et al.
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide2012
Dr Jane Renwick
Dr Robert Ellis
Dr Nigel Kirkham
Professor Penny Lovat
WIPI-1: a novel autophagy inhibitory protein in melanoma2012
Dr Robert Ellis
Dr Jane Renwick
Christopher McKee
Dr Nigel Kirkham
Professor Penny Lovat
et al.
Biomarkers of defective autophagy in melanoma2011
Dr Jane Renwick
Dr Robert Ellis
Dr Nigel Kirkham
Professor Penny Lovat
Defective autophagy in melanoma development and progression: role of oncogenic B-RAF signalling2011
Dr Alison Forrester
Professor Penny Lovat
Professor Faith Williams
Professor Nick Reynolds
Differential activation of the aryl hydrocarbon receptor and regulation of differentiation in the epidermal equivalent model2011
Dr Jane Renwick
Shaun Martin
Dr David Hill
Nicola Townshend
Dr Chris Redfern
et al.
Oncogenic B-RAF Signaling in Melanoma Impairs the Therapeutic Advantage of Autophagy Inhibition2011
Dr Jane Renwick
Dr Robert Ellis
Professor Penny Lovat
Role of defective autophagy in melanoma development and progression: implication of oncogenic B-RAF signalling2011
Christopher McKee
Professor Penny Lovat
Dr Jane Renwick
Role of Mcl-1 in the resistance of B-RAF mutated melanoma to autophagy2011
Dr Jane Renwick
Professor Penny Lovat
Oncogenic BRAF signalling confers resistance of metastatic melanoma to autophagy2010
Dr Jane Renwick
Dr Ross Flockhart
Professor Gareth Veal
Professor Penny Lovat
Dr Chris Redfern
et al.
Regulation of Endoplasmic Reticulum Stress-induced Cell Death by ATF4 in Neuroectodermal Tumor Cells2010
Dr Robert Ellis
Dr Emma Hiscutt
Professor Penny Lovat
Dr Jane Renwick
Role of Bcl-2 family proteins in oncogenic BRAF-induced resistance of melanoma to autophagy2010
Shaun Martin
Dr David Hill
Professor Mark Birch-Machin
Professor Penny Lovat
Dr Chris Redfern
et al.
Targeting GRP78 to enhance melanoma cell death2010
Dr Emma Hiscutt
Dr David Hill
Shaun Martin
Dr Andrew Harbottle
Professor Mark Birch-Machin
et al.
Targeting X-Linked Inhibitor of Apoptosis Protein to Increase the Efficacy of Endoplasmic Reticulum Stress-Induced Apoptosis for Melanoma Therapy2010
Professor Penny Lovat
Dr Ralph Jans
The antioxidant-response regulator Nrf2 is overexpressed in melanoma cells and further induced by oxidative stress - validation of Nrf2 as a novel adjuvant target for melanoma treatment2010
Dr David Hill
Shaun Martin
Dr Jane Renwick
Dr Ross Flockhart
Dominic Simpson
et al.
Combining the endoplasmic reticulum stress-inducing agents bortezomib and fenretinide as a novel therapeutic strategy for metastatic melanoma2009
Professor Penny Lovat
Dr Jane Renwick
Shaun Martin
Dr David Hill
Dr Chris Redfern
et al.
Increasing Melanoma Cell Death Using Inhibitors of Protein Disulphide Isomerases to Abrogate Survival Responses to Endoplasmic Reticulum Stress2009
Professor Nick Reynolds
Dr Ross Flockhart
Dr Jane Renwick
Professor Penny Lovat
NFAT signalling in metastatic melanoma: a novel target for oncogenic B-RAF2009
Dr Ross Flockhart
Dr Jane Renwick
Professor Nick Reynolds
Professor Penny Lovat
NFAT signalling is a novel target of oncogenic BRAF in metastatic melanoma2009
Dr Emma Hiscutt
Dr David Hill
Shaun Martin
Dr Ross Flockhart
Dr Jane Renwick
et al.
Targeting XIAP to increase endoplasmic reticulum stress-induced apoptosis of malignant melanoma2009
Dr David Hill
Dr Jane Renwick
Professor Mark Birch-Machin
Professor Penny Lovat
B-RAF signalling in endoplasmic reticulum stress-induced apoptosis of metastatic melanoma2008
Shaun Martin
Dr David Hill
Dr Jane Renwick
Professor Mark Birch-Machin
Dr Chris Redfern
et al.
Combining endoplasmic reticulum stress-inducing agents with protein disulphide isomerase inhibition: a novel therapeutic strategy for metastatic melanoma2008
Professor Penny Lovat
Shaun Martin
Dr Jane Renwick
Dr Chris Redfern
Professor Mark Birch-Machin
et al.
Combining ER-stress-induced apoptosis with protein disulphide isomerase inhibition as a novel therapeutic strategy for metastatic melanoma2008
Diana Levett
Shaun Martin
Professor Penny Lovat
Professor Mark Birch-Machin
Endoplasmic reticulum stress-induced apoptosis in response to imiquimod: a novel therapeutic strategy for metastatic squamous cell carcinoma?2008
Dr Katrina Wood
Dr Michael Jackson
Dr Maria Lastowska
Dr Darroch Hall
Dr Helen Imrie
et al.
Histological profile of tumours from MYCN transgenic mice2008
Professor Penny Lovat
Dr Jane Renwick
Shaun Martin
Dr David Hill
Professor Mark Birch-Machin
et al.
Increasing melanoma cell death using inhibitors of protein disulfide isomerases to abrogate survival responses to endoplasmic reticulum stress2008
Dr Ross Flockhart
Professor Nick Reynolds
Professor Penny Lovat
NFAT signalling in malignant melanoma2008
Professor Penny Lovat
Dr Chris Redfern
Professor Mark Birch-Machin
Combining endoplasmic reticulum stress-inducing agents with protein disulphide isomerase inhibitors as a novel therapeutic strategy for metastatic melanoma2007
Professor Penny Lovat
Dr Chris Redfern
Professor Mark Birch-Machin
Combining ER-stress inducing agents with protein disulphide inhibitors as a novel therapeutic strategy for metastatic melanoma2007
Dr David Hill
Dr Jane Renwick
Professor Mark Birch-Machin
Professor Penny Lovat
Defining the role of B-RAF-induced extracellular signal-related kinase in the resistance of metastatic melanoma to apoptosis2007
Dr Jane Renwick
Professor Gareth Veal
Dr Chris Redfern
Professor Penny Lovat
Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours2007
Professor Penny Lovat
Dr Jane Renwick
Dr David Hill
Professor Mark Birch-Machin
Dr Chris Redfern
et al.
Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis: The role of stress proteins ERdj5 and ERp572007
Professor Penny Lovat
Dr Andrew Harbottle
Dr Chris Redfern
Professor Mark Birch-Machin
Fenretinide-induced apoptosis via endoplasmic reticulum stress - new drug targets for melanoma therapy?2006
Dr Emma Bell
Dr Jane Carr-Wilkinson
Dr Xiaohong Lu
Professor Penny Lovat
Professor John Lunec
et al.
The role of MYCN in the failure of MYCN amplified neuroblastoma cell lines to G1 arrest after DNA damage2006
Professor Penny Lovat
Dr Chris Redfern
Fenretinide: A p53-independent way to kill cancer cells2005
Dr Quentin Campbell Hewson
Professor Penny Lovat
Dr Jonathan Catterall
Dr Chris Redfern
The NF-κB pathway mediates fenretinide-induced apoptosis in SH-SY5Y neuroblastoma cells2005
Professor Penny Lovat
Dr Chris Redfern
The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma2005
Professor Penny Lovat
Professor Andrew Pearson
Emeritus Professor Andy Hall
Dr Chris Redfern
Gangliosides link the acidic sphingomyelinase-mediated induction of ceramide to 12-lipoxygenase-dependent apoptosis of neuroblastoma in response to fenretinide2004
Professor Penny Lovat
Bojidar Goranov
Dr Chris Redfern
Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells2004
Professor Penny Lovat
Bojidar Goranov
Dr Chris Redfern
Molecular mechanisms of fenretinide-induced apoptosis of neuroblastoma cells2004
Professor Penny Lovat
Bojidar Goranov
Dr Chris Redfern
Bak: A Downstream Mediator of Fenretinide-Induced Apoptosis of SH-SY5Y Neuroblastoma Cells2003
Professor Penny Lovat
Glucosylceramide synthase and its functional interaction with RTN-1C regulate chemotherapeutic-induced apoptosis in neuroepithelioma cells2003
Professor Penny Lovat
Professor Andrew Pearson
Dr Chris Redfern
Growth and DNA Damage-Inducible Transcription Factor 153 Mediates Apoptosis in Response to Fenretinide but Not Synergy between Fenretinide and Chemotherapeutic Drugs in Neuroblastoma2003
Professor Penny Lovat
Professor Andrew Pearson
Dr Chris Redfern
Induction of GADD153 and Bak: Novel molecular targets of fenretinide-induced apoptosis of neuroblastoma2003
Professor Penny Lovat
Professor Andrew Pearson
Dr Chris Redfern
Mechanisms of free-radical induction in relation to fenretinide-induced apoptosis of neuroblastoma2003
Professor Penny Lovat
Dr Quentin Campbell Hewson
Professor Andrew Pearson
Dr Chris Redfern
GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma2002
Dr Quentin Campbell Hewson
Professor Penny Lovat
Professor Andrew Pearson
Dr Chris Redfern
Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARβ expression2002
Professor Penny Lovat
Dr Chris Redfern
Professor Andrew Pearson
Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway2001
Professor Penny Lovat
Dr Mark Dobson
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells2001
Professor Penny Lovat
Dr Michael Tilby
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents2000
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
Effector mechanisms of fenretinide-induced apoptosis in neuroblastoma2000
Dr Quentin Campbell Hewson
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Receptor mechanisms mediating differentiation and proliferation effects of retinoids on neuroblastoma cells2000
Professor Penny Lovat
Dr Michael Tilby
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs2000
Professor Penny Lovat
Dr Mark Dobson
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Differential effects of retinoic acid isomers on the expression of nuclear receptor co-regulators in neuroblastoma1999
Professor Penny Lovat
Dr Chris Redfern
Professor Andrew Pearson
Apoptosis in neuroblastomas induced by interferon-γ involves the CD95/CD95L pathway1998
Professor Penny Lovat
Dr Mark Dobson
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Differential gene regulation by 9-cis and all-trans retinoic acid in neuroblastoma cells1998
Professor Penny Lovat
Dr Quentin Campbell Hewson
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
et al.
Retinoid-induced differentiation of neuroblastoma: Comparison between LG69, an RXR-selective analogue and 9-cis retinoic acid1998
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
9-cis retinoic acid - A better retinoid for the modulation of differentiation, proliferation and gene expression in human neuroblastoma1997
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
Apoptosis of N-type neuroblastoma cells after differentiation with 9- cis-retinoic acid and subsequent washout1997
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Dr Chris Redfern
Retinoids in neuroblastoma therapy: Distinct biological properties of 9- cis- and all-trans-retinoic acid1997
Dr Chris Redfern
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Gene expression and neuroblastoma cell differentiation in response to retinoic acid: differential effects of 9-cis and all-trans retinoic acid1995
Professor Penny Lovat
Professor Andrew Pearson
Professor Archibald Malcolm
Dr Chris Redfern
Concentration-dependent effects of 9-cis retinoic acid on neuroblastoma differentiation and proliferation in vitro1994
Dr Chris Redfern
Professor Penny Lovat
Professor Archibald Malcolm
Professor Andrew Pearson
Differential effects of 9-cis and all-trans retinoic acid on the induction of retinoic acid receptor-beta and cellular retinoic acid-binding protein II in human neuroblastoma cells1994
Professor Penny Lovat
Professor Andrew Pearson
Professor Archibald Malcolm
Dr Chris Redfern
Retinoic acid receptor expression during the in vitro differentiation of human neuroblastoma1993